Exogenus
Therapeutics
Exogenus Therapeutics is an early-stage research and development company developing healthcare solutions based on Extracellular Vesicles (EVs) and Exosomes. Founded in 2015,
Exogenus is a pioneer in the field of EVs/Exosome-based therapeutics, and a recognized innovator in Umbilical Cord Blood clinical use. Leveraging on its experience and recognition in this space, Exogenus mission is to foster a new era of EVs/Exosomes-based solutions to solve major healthcare challenges, based on the development of its own products, and providing guidance to other partners developing this type technologies for clinical use.
Latest news
Exogenus’ Scientic Officer speaker at World Advanced Therapies and Regenerative Medicine Congress 2019
Joana Correia, founder, Executive Director and Chief Scientific Officer of Exogenus Therapeutics will be presenting at the 14th World Advanced Therapies and Regenerative Medicine Congress...
Exogenus Therapeutics wins Prémio Empreendedor XXI 2018
Exogenus Therapeutics is the winner of the 2nd edition of Prémio Empreendedor XXI, Portugal - North and Central Regions. This prize is organized by BPI and DayOne, a division of CaixaBank...
Exogenus Therapeutics on the Top 500 deeptech startups shortlist of Hello Tommorrow
Exogenus is amongst the 500 deeptech startups running for the Hello Tomorrow Global Challenge. The Hello Tomorrow Global Challenge is a worldwide renowned science...